Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.

Real-World Sex Differences in Response to Treatment with Glucagon-like Peptide-1 Receptor Agonists: Analysis of Single-Center Outpatient Case Series

Open access

Abstract

Background and Objectives: Type 2 diabetes (T2D) is a global health burden with increasing prevalence, necessitating effective management strategies. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as beneficial therapies, promoting both glycemic control and weight loss, yet real-world data on sex differences in response are limited. This study aimed to investigate sex-based differences in glycemic and weight outcomes, as well as adverse effects, in T2D patients treated with GLP-1 RAs at a single diabetes center. Materials and Methods: In this retrospective analysis, 114 patients (58.8% men) with T2D who were initiated on GLP-1 RA therapy between 2015 and 2023 were evaluated. Data on HbA1c, BMI, and adverse events were collected at baseline and 3, 6, and 12 months post-treatment initiation. Results: Our findings indicated a statistically significant HbA1c reduction (from 8.6% at GLP-1 RA initiation to 6.9% at 12 months in men (p < 0.001) and from 8.4% at initiation to 7.0% at 12 months after GLP-1 RA initiation (p < 0.001) in women). By 12 months, a significantly greater proportion of women compared to men achieved ≥ 5% (51.1% vs. 28.4%, p = 0.019) and ≥10% weight loss (29.8% vs. 9.0%, p = 0.006), with both differences reaching statistical significance. A statistically significant difference in weight loss in mean weight change and percent weight change in men vs. women was observed from month 6 of therapy. Conclusions: These findings underscore the effectiveness of GLP-1 RAs in improving glycemic control and weight loss in a real-world setting and suggest that women may experience greater weight reduction. Understanding these differences could inform personalized treatment strategies for optimized outcomes in T2D management.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/medicina61081343

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Mean HbA1c change by sex (a) and percentage of men and women with an HbA1c < 7% at 3, 6, and 12 months (b). No statistically significant difference in HbA1c between women and men was observed at any timepoint (p > 0.05; Mann–Whitney U test). A statistically significant higher percentage of men achieved and HbA1c < 7% at 3 months (p = 0.029, chi-square test).
Figure 1 Mean HbA1c change by sex (a) and percentage of men and women with an HbA1c < 7% at 3, 6, and 12 months (b). No statistically significant difference in HbA1c between women and men was observed at any timepoint (p > 0.05; Mann–Whitney U test). A statistically significant higher percentage of men achieved and HbA1c < 7% at 3 months (p = 0.029, chi-square test).CC BY · PubMed Central
Figure 2 Linear association of HbA1c change at 3, 6, and 12 months with HbA1c at GLP-1 RA initiation in men (a) and women (b).
Figure 2 Linear association of HbA1c change at 3, 6, and 12 months with HbA1c at GLP-1 RA initiation in men (a) and women (b).CC BY · PubMed Central
Figure 3 Mean (a) and percent (b) weight change at 3, 6, and 12 months. * denotes statistically significant difference of percent weight change in men vs. women at 6 months (p = 0.026) and 12 months (p = 0.011). At each timepoint men and women were compared using the Mann–Whitney U test.
Figure 3 Mean (a) and percent (b) weight change at 3, 6, and 12 months. * denotes statistically significant difference of percent weight change in men vs. women at 6 months (p = 0.026) and 12 months (p = 0.011). At each timepoint men and women were compared using the Mann–Whitney U test.CC BY · PubMed Central
Figure 4 Linear association of weight change at 3, 6, and 12 months with weight at GLP-1 RA initiation in men (a) and women (b).
Figure 4 Linear association of weight change at 3, 6, and 12 months with weight at GLP-1 RA initiation in men (a) and women (b).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Cited by

See all 4

Metadata

Authors
Inceu, G. V., Crăciun, A.-E., Ciobanu, D. M., Berchisan, A., Fodor, A., Bala, C., Roman, G., & Rusu, A.
Affiliations
  • Iuliu Hațieganu University of Medicine and Pharmacy (RO)
  • Department of Diabetes and Nutrition Diseases, “Iuliu Hațieganu” University of Medicine and Pharmacy, 2-4 Clinicilor St., 400006 Cluj-Napoca, Romania
  • Spitalul Clinic Județean de Urgență Cluj-Napoca (RO)
Venue
Medicina
Publisher
MDPI AG
Published
2025-07-25
Volume
61
Issue
8
Pages
1343
ISSN
  • 1010-660X (ISSN-L)
  • 1648-9144
OpenAlex
W4412917849
Cited by
3
References
47
Citations by year
2026: 3
FWCI
2.04
Type
journal article
Language
en
Open access
Locations
  • Medicina (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
“Iuliu Hatieganu” University of Medicine and Pharmacy
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Sex and Gender in Healthcare
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
type 2 diabetes, GLP-1 receptor agonists, sex differences, glycemic control, HbA1c, weight loss, adverse events, real-world effectiveness, women
MeSH terms
Glycemic Control, Glucagon-Like Peptide-1 Receptor Agonists, Aged, Body Weight, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Male, Middle Aged, Retrospective Studies, Sex Factors, Weight Loss, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Real-World Sex Differences in Response to Treatment with Glucagon-like Peptide-1 Receptor Agonists: Analysis of Single-Center Outpatient Case Series. https://app.cochat.ai/papers/10.3390/medicina61081343
The paper
Inceu, G. V., Crăciun, A.-E., Ciobanu, D. M., Berchisan, A., Fodor, A., Bala, C., Roman, G., & Rusu, A. (2025). Real-World Sex Differences in Response to Treatment with Glucagon-like Peptide-1 Receptor Agonists: Analysis of Single-Center Outpatient Case Series. Medicina. https://doi.org/10.3390/medicina61081343

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.